# Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

> **NCT00671749** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 100 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** adapalene gel, 0.3%
- **DRUG:** clindamycin/benzoyl peroxide gel

## Key facts

- **NCT ID:** NCT00671749
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671749, "Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00671749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*